Dec 02, 2019
Mylan and Biocon Launch Trastuzumab Biosimilar, Ogivri(TM) (trastuzumab-dkst), in the U.S.
Sep 26, 2019
Kiran Mazumdar-Shaw Promises to Enable Universal Access to rh-Insulin by Reducing Prices to Less than 10 US cents /Day for LMICs
Sep 16, 2019
Kas Subramanian, PhD Joins Applied BioMath, LLC as Senior Director of Preclinical Modeling
Jul 29, 2019
Biologics Fill / Finish Services Market, 2030 by Type of Packaging, Additional Services Offered, Scale of Operation, Type of Biologics Filled
Jul 24, 2019
Biologics Fill / Finish Services Market, 2019 - 2030
Jun 20, 2019
WuXi Biologics to Expand Integrated Biologics Conjugation Solution Center to Include Commercial Manufacturing
Jun 11, 2019
Visiongain Report Claims There is Huge Potential Within the $57bn Biosimilar Drugs Market
May 02, 2019
United States Biosimilars Market Outlook to 2025: Clinical Pipeline by Company, Indication & Phase of 28 Biosimilars & 9 Marketed Biosimilars
Apr 24, 2019
Global $200+ Billion Drug API Market Forecasts to 2024 with Teva Pharmaceutical Industries, Dr. Reddy's Laboratories, Aurobindo Pharma and Cipla Dominating
Mar 19, 2019
Follow-on Biologics Market Growth, Size, Statistics, Key Trends, Developments & Opportunities: Radiant Insights, Inc.
Feb 03, 2019
GeneQuantum Healthcare and MITRO Biotech Enter into Strategic Cooperation to Develop Next Generation Radionuclide Conjugates
Jan 23, 2019
Global Biosimilars Market - Increasingly Lucrative Market Fueled by Constrained Payer Environment and Patent Expiries for Best-Selling Biologics- ReportsnReports
Jan 22, 2019
Global Biosimilars Market 2017-2019 & 2024: Total of 492 Products in Development Featuring Amgen, Biocon, Celltrion, Dr. Reddy's Laboratories, Pfizer, Samsung Bioepis & Sandoz
Dec 13, 2018
Sanofi's Formulation Patents on Multibillion-Dollar Lantus® are Invalidated by U.S. Patent and Trademark Office via IPR, Announces Mylan
Nov 28, 2018
Ajinomoto Bio-Pharma Services Introduces AJICAP Bioconjugation Technology for ADC Manufacturing
Nov 26, 2018
Visiongain Report Looks at Opportunities Within the $250bn Biologics Sector
Nov 21, 2018
Global Insulin Delivery Devices Market 2017-2018 & 2025: Opportunities in Increasing Medical Tourism In Emerging Nations & Growing Product Innovations
Nov 01, 2018
Global Biosimilars Market Report 2018-2025 - Patent Expiration of Biologics to Boost the Biosimilars Market
Oct 19, 2018
Mylan and Biocon Announce Positive CHMP Opinion for Ogivri®, Biosimilar Trastuzumab
Sep 25, 2018
Biosimilars Market Size Worth $61.47 Billion by 2025 | CAGR: 34.2%: Grand View Research, Inc.